These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27306167)

  • 1. Promising gene therapies pose million-dollar conundrum.
    Check Hayden E
    Nature; 2016 Jun; 534(7607):305-6. PubMed ID: 27306167
    [No Abstract]   [Full Text] [Related]  

  • 2. Orkambi's Slick Unveiling Puts Insurers in a Bind.
    Silverman E
    Manag Care; 2015 Aug; 24(8):16-7. PubMed ID: 26399136
    [No Abstract]   [Full Text] [Related]  

  • 3. Cystic Fibrosis Trust's clarification of Cohen and Raftery's article on cystic fibrosis drug development.
    Owen E
    BMJ; 2014 Mar; 348():g1849. PubMed ID: 24603568
    [No Abstract]   [Full Text] [Related]  

  • 4. Pricing for orphan drugs: will the market bear what society cannot?
    O'Sullivan BP; Orenstein DM; Milla CE
    JAMA; 2013 Oct; 310(13):1343-4. PubMed ID: 24084916
    [No Abstract]   [Full Text] [Related]  

  • 5. Paying twice: questions over high cost of cystic fibrosis drug developed with charitable funding.
    Cohen D; Raftery J
    BMJ; 2014 Feb; 348():g1445. PubMed ID: 24523379
    [No Abstract]   [Full Text] [Related]  

  • 6. Hot off the breath: 'I've a cost for'--the 64 million dollar question.
    Bush A; Simmonds NJ
    Thorax; 2012 May; 67(5):382-4. PubMed ID: 22407889
    [No Abstract]   [Full Text] [Related]  

  • 7. A new model for drug development using a multi-stakeholder consortium.
    Hall AK
    BMJ; 2014 Mar; 348():g1850. PubMed ID: 24603569
    [No Abstract]   [Full Text] [Related]  

  • 8. New cystic fibrosis drug paves the way for orphan diseases.
    Cooney D
    Lancet Respir Med; 2013 Apr; 1(2):104. PubMed ID: 24429084
    [No Abstract]   [Full Text] [Related]  

  • 9. Lumacaftor/ivacaftor (Orkambi) for cystic fibrosis.
    Med Lett Drugs Ther; 2016 Mar; 58(1491):41-2. PubMed ID: 27027688
    [No Abstract]   [Full Text] [Related]  

  • 10. Settlement reached over medicaid coverage of cystic fibrosis drug: Arkansas federal court case highlights medical necessity, high cost of targeted therapies.
    Am J Med Genet A; 2015 Apr; 167A(4):viii-ix. PubMed ID: 25820402
    [No Abstract]   [Full Text] [Related]  

  • 11. Precision Medicine: At What Price?
    Ferkol T; Quinton P
    Am J Respir Crit Care Med; 2015 Sep; 192(6):658-9. PubMed ID: 26207804
    [No Abstract]   [Full Text] [Related]  

  • 12. Personalized medicine. New cystic fibrosis drug offers hope, at a price.
    Kaiser J
    Science; 2012 Feb; 335(6069):645. PubMed ID: 22323790
    [No Abstract]   [Full Text] [Related]  

  • 13. Cystic fibrosis drug is not cost effective, says NICE.
    Gulland A
    BMJ; 2016 Jun; 353():i3409. PubMed ID: 27325384
    [No Abstract]   [Full Text] [Related]  

  • 14. MEDICINE. Paying for future success in gene therapy.
    Orkin SH; Reilly P
    Science; 2016 May; 352(6289):1059-61. PubMed ID: 27230368
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene therapy is facing its biggest challenge yet.
    Ledford H
    Nature; 2019 Dec; 576(7785):22-25. PubMed ID: 31797915
    [No Abstract]   [Full Text] [Related]  

  • 16. Why these biotechs are as hot as net stocks. Wall Street's betting big on a genetic technology that burned it badly before. Monoclonal antibodies still don't cure cancer--but this time they may actually pay off.
    McLean B
    Fortune; 2000 Jan; 141(1):132-4, 135. PubMed ID: 10788044
    [No Abstract]   [Full Text] [Related]  

  • 17. Specialty Pharmaceuticals for Hyperlipidemia--Impact on Insurance Premiums.
    Schulman KA; Balu S; Reed SD
    N Engl J Med; 2015 Oct; 373(17):1591-3. PubMed ID: 26444460
    [No Abstract]   [Full Text] [Related]  

  • 18. The Double-Edged Sword of Extremely High Prices for Gene Therapies in Sickle Cell Disease.
    Cliff ERS; Tessema FA
    JAMA; 2024 Sep; 332(9):703-704. PubMed ID: 39102257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis in an era of genomically guided therapy.
    Barrett PM; Alagely A; Topol EJ
    Hum Mol Genet; 2012 Oct; 21(R1):R66-71. PubMed ID: 22914736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Therapy Entering the Land of Oz.
    Wilson JM
    Hum Gene Ther Clin Dev; 2018 Dec; 29(4):171. PubMed ID: 30576251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.